Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Early Trial Data Show Crispr Cancer Therapy Response

Crispr genome edits illustration

Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects. . . . → Read More: Early Trial Data Show Crispr Cancer Therapy Response

Trial Set for Ingested Colon Cancer Detection Capsule

Detect cancer scrabble

A clinical trial is set to begin assessing an electronic capsule designed to detect and transmit images from the gut to detect early cancer-causing polyps. . . . → Read More: Trial Set for Ingested Colon Cancer Detection Capsule

Partnership Developing Faster, Sensitive Covid-19 Test

SARS-CoV-2 and cell

A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test

AI-Aided Cancer Analytics Gain $21.5M in Early Funds

Artificial intelligence graphic

A start-up enterprise using artificial intelligence algorithms to analyze tumor biopsy images is raising $21.5 million in seed and first-round venture funding. . . . → Read More: AI-Aided Cancer Analytics Gain $21.5M in Early Funds

State Grant Funds Virus-Immunotherapy Cancer Trial

T-cells and cancer cells

A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial

Early Trials Show Responses for Some Blood Cancers

Natural killer cell

First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers

Trial Begins Testing Crispr Gut Microbiome Therapy

E. coli

A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy

Natural Killer Cells Stop Ovarian Cancer in Preclinical Test

Natural killer cell

Results from a lab study show engineered immune system cells sharply reduce tumors and extend survival in mice grafted with a type of ovarian cancer. . . . → Read More: Natural Killer Cells Stop Ovarian Cancer in Preclinical Test

Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

T-cells and cancer cells

A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

Trial to Test AI-Designed Cancer Antibody Therapy

Cancer magnified

A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms. . . . → Read More: Trial to Test AI-Designed Cancer Antibody Therapy